"Effect of Nettles in treatment of diabetes"

Evaluation of the Urtica Dioica effect on blood glucose parameters and lipidprofile in patients with type 2 diabetes: a randomized double-blind clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230313057707N1

Enrollment

106

Registered

2023-05-04

Start date

2023-07-23

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: The nettle group will receive 2 capsules of 250 mg, which will contain 25 mg of the active substance of nettle along with fillers, every 12 hours for 3 months. The

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Having diabetes type 2

Exclusion criteria

Exclusion criteria: Allergy

Design outcomes

Primary

Measure	Time frame
The percentage of people who have a fasting blood sugar level above 120 mg/dl. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting blood sugar test.	—

Secondary

Measure	Time frame
HbA1C. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: HbA1C test.;Creatinine. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Creatinine test.;Fasting insulin. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting insulin test.;Cholesterol. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Cholesterol test.;Triglyceride. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Triglyceride test.	—

Measure

Time frame

HbA1C. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: HbA1C test.;Creatinine. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Creatinine test.;Fasting insulin. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting insulin test.;Cholesterol. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Cholesterol test.;Triglyceride. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Triglyceride test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Khosravi

Kian Pharmed Parsian

elhamfaghani69@yahoo.com+98 21 6694 4081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026